MRO Acquires Q-Centrix: Clinical Data Management Boost
- MRO, a clinical data exchange company based in the U.S., has acquired Q-Centrix, an enterprise clinical data management platform previously owned by TPG Growth.
- The company said the deal is expected to provide scalable value for healthcare providers, payers, and life sciences by supporting more precise decision-making and broader clinical applications.
- The combined entity will provide services to more than 2,000 health systems and hospitals, along with over 7,000 clinics and nearly 250 payers.
MRO‘s acquisition of Q-Centrix signals a major shift in clinical data management. This strategic move enhances clinical data exchange by combining MRO’s robust solutions with Q-Centrix’s enterprise platform. The goal? To transform fragmented data into actionable insights, ultimately helping healthcare providers make better decisions. This powerful combination will serve over 2,000 health systems, optimizing clinical data management and fostering more effective patient care and improved research capabilities across the healthcare ecosystem. News Directory 3 has the exclusive details on this significant industry advancement. Eager to learn about the implications? Discover what’s next in healthcare innovation.
MRO Acquires Q-Centrix to Boost Clinical data Management
Updated June 13, 2025
MRO, a clinical data exchange company based in the U.S., has acquired Q-Centrix, an enterprise clinical data management platform previously owned by TPG Growth. The acquisition aims to transform fragmented clinical data into actionable insights for hospitals and health systems.
The company said the deal is expected to provide scalable value for healthcare providers, payers, and life sciences by supporting more precise decision-making and broader clinical applications. Q-Centrix’s platform is designed to reduce complexity and expedite decisions.
The combined entity will provide services to more than 2,000 health systems and hospitals, along with over 7,000 clinics and nearly 250 payers. By enriching and curating clinical data, MRO and Q-Centrix seek to facilitate wider clinical applications.
“At MRO, we believe there is tremendous untapped value in unlocking and leveraging clinical data that resides in fragmented, siloed systems today,” MRO CEO Jason Brown said.
Brown added that combining MRO’s clinical data exchange solutions with Q-Centrix’s clinical data management capabilities creates a platform for acquiring, abstracting, curating, and exchanging clinical data to improve patient care and reduce costs across the healthcare ecosystem. parthenon Capital, a healthcare technology investor, supports the acquisition with a new investment in MRO. The financial terms of the deal were not disclosed.
“MRO and Q-Centrix share a commitment to advancing the industry in service of our customers,” said Q-Centrix CEO Milton Silva-Craig. “That focus is fuelling the creation of a first-of-its-kind platform—seamlessly integrating systems and delivering structured,highly valuable data sets to support clinical care,operational performance,breakthrough research,and regulatory compliance.”
What’s next
The acquisition is expected to drive further innovation in clinical data management,enabling healthcare providers to make more informed decisions and improve patient outcomes through enhanced clinical data exchange.